CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 16:00:02 2026-10-02 EDT			5-day change	1st Jan Change
290.19 ^USD	+1.17%		-1.44%	+45.47%

09-30	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
09-29	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT

Insiders

08-20	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
08-13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-06	Charles River Laboratories International Insider Sold Shares Worth $1,327,098, According to a Recent SEC Filing	MT
07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
05-11	Charles River Laboratories International, Inc. Announces Board Elections	CI
02-18	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-18	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
01-12	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-12	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
25-10-15	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
25-09-16	Charles River Laboratories announces chief financial officer transition	RE
25-09-16	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
25-09-16	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
25-09-16	Charles River Laboratories Says CFO to Step Down	MT
25-05-07	Charles River to add new directors, review business in agreement with Elliott	RE
25-05-07	Charles River Laboratories International, Inc. Announces Board Changes	CI
24-11-12	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
24-08-12	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
24-03-04	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
24-03-01	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT